VA8-54901-05692
3 vaccinations
2 coded responses
36 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 554 / MN
- Registered
- 2021-02-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-27
Dose 1 — Moderna
-
2021-02-28
Registered in v-safe
-
2021-02-28
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-02
- 2021-03-04
- 2021-03-05
- 2021-03-06
-
2021-03-13
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site pruritus, Injection site rash, Rash macular — Feeling: GoodFree text: Red splotch and slightly itchy around site of injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-20
-
2021-03-27
Dose 2 — Moderna
- 2021-03-27
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-11
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-05-08
- 2021-06-26
- 2021-09-25
-
2021-11-13
Dose 3 — Pfizer-BioNTech
- 2021-11-13
-
2021-11-14
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-15
- 2021-11-16
- 2021-11-18
- 2021-11-19
- 2021-11-27
- 2021-12-04
- 2021-12-18
- 2021-12-25
- 2022-02-12
-
2022-05-14
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-05-14
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-17
- 2022-11-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-27 | Moderna | |
| 2 | 2021-03-27 | Moderna | |
| 3 | 2021-11-13 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-14 | Unsuccessful |
Free text
Release 5 — day 14, dose 1
Symptoms: Red splotch and slightly itchy around site of injection
Release 11 — 6 months, dose 3
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Rash macular | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release